I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Allersma, Derk P
26
results:
Search for persons
X
Format
Online (26)
Mediatypes
Articles (Online) (10)
Bookchapter (Online) (1)
OpenAccess-fulltext (15)
Sorted by: Relevance
Sorted by: Year
?
1
Performance of Tablet Splitters, Crushers, and Grinders in ..:
Woerdenbag, Herman J.
;
Visser, J. Carolina
;
Leferink op Reinink, Marlyn P. A. M.
...
Pharmaceutics. 14 (2022) 2 - p. 320 , 2022
Link:
https://doi.org/10.3390/..
?
2
Development of a Personalized Tumor Neoantigen Based Vaccin..:
Oosting, Linette T.
;
Franke, Katka
;
Martin, Michael V.
...
Pharmaceutics. 14 (2022) 7 - p. 1515 , 2022
Link:
https://doi.org/10.3390/..
?
3
Enantiomer‐specific pharmacokinetics of D,L‐3‐hydroxybutyra..:
van Rijt, Willemijn J.
;
Van Hove, Johan L. K.
;
Vaz, Frédéric M.
...
Journal of Inherited Metabolic Disease. 44 (2021) 4 - p. 926-938 , 2021
Link:
https://doi.org/10.1002/..
?
4
First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:
Komdeur, Fenne L.
;
Singh, Amrita
;
van de Wall, Stephanie
...
Molecular Therapy. 29 (2021) 2 - p. 611-625 , 2021
Link:
https://doi.org/10.1016/..
?
5
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccin..:
Jorritsma-Smit, Annelies
;
van Zanten, Coba J.
;
Schoemaker, Jolande
...
European Journal of Pharmaceutical Sciences. 143 (2020) - p. 105096 , 2020
Link:
https://doi.org/10.1016/..
?
6
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) tre..:
van Rijt, Willemijn J.
;
Jager, Emmalie A.
;
Allersma, Derk P.
...
Genetics in Medicine. 22 (2020) 5 - p. 908-916 , 2020
Link:
https://doi.org/10.1038/..
?
7
Performance of Tablet Splitters, Crushers, and Grinders in ..:
Woerdenbag, Herman J
;
Visser, J Carolina
;
Leferink Op Reinink, Marlyn P A M
...
https://research.rug.nl/en/publications/7f7b7de2-4be8-4a5e-a74f-3d073709be61. , 2022
Link:
https://hdl.handle.net/1..
?
8
Development of a Personalized Tumor Neoantigen Based Vaccin..:
Oosting, Linette T
;
Franke, Katka
;
Martin, Michael
...
https://research.rug.nl/en/publications/fb374d3c-37d2-4e25-9b9a-6989207e4944. , 2022
Link:
https://hdl.handle.net/1..
?
9
Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyra..:
van Rijt, Willemijn J
;
Van Hove, Johan L K
;
Vaz, Frédéric M
...
https://research.rug.nl/en/publications/93d5b621-c257-44f1-b540-264e80f777f9. , 2021
Link:
https://hdl.handle.net/1..
?
10
First-in-Human Phase I Clinical Trial of an SFV-Based RNA R..:
Komdeur, Fenne L
;
Singh, Amrita
;
van de Wall, Stephanie
...
https://research.rug.nl/en/publications/5172de71-9650-4d26-b08d-9a20ba7f7564. , 2021
Link:
https://hdl.handle.net/1..
?
11
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) tre..:
van Rijt, Willemijn J
;
Jager, Emmalie A
;
Allersma, Derk P
...
https://research.rug.nl/en/publications/a0c31d78-7beb-4424-b1f8-867d53b7b9af. , 2020
Link:
https://hdl.handle.net/1..
?
12
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) tre..:
Van Rijt, Willemijn J
;
Jager, Emmalie A
;
Allersma, Derk P
...
Genetics In Medicine. , 2020
Link:
https://doi.org/10.1038/..
?
13
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) tre..:
van Rijt, Willemijn J
;
Jager, Emmalie A
;
Allersma, Derk P
...
https://mediatum.ub.tum.de/1554240. , 2020
Link:
https://mediatum.ub.tum...
?
14
GMP manufacturing of Vvax001, a therapeutic anti-HPV vaccin..:
Jorritsma-Smit, Annelies
;
van Zanten, Coba J
;
Schoemaker, Jolande
...
https://research.rug.nl/en/publications/407cb898-43fc-4871-8544-fcd448e4e608. , 2020
Link:
https://hdl.handle.net/1..
?
15
Efficacy and safety of D,L-3-hydroxybutyrate (D,L-3-HB) tre..:
van Rijt, Willemijn J
;
Jager, Emmalie A
;
Allersma, Derk P
...
https://boris.unibe.ch/138671/. , 2020
Link:
https://boris.unibe.ch/1..
1-15